Wikipedia -WSS

Wikipedia

author：knowledge 2025-08-12 11:28:20 - browse：94

Illustration of three connected puzzle pieces, with a woman standing near the missing/empty puzzle piece space. -- first opinion coverage from STAT — Adobe

Women have always been underrepresented in medical research. A new study reveals that not much has changed, especially when it comes to tests of cardiovascular devices.

In a paper published in JAMA Internal Medicine on Monday, researchers found that the percentage of women represented in high-risk medical device trials did not increase from 2010 to 2020. Women generally made up just 33% of participants when the team reviewed 195 trials published from 2016 to 2022. The percentages varied between devices: Women made up 46% of participants in orthopedic trials, but 29% in cardiovascular studies.

The issue isn’t new. The government has made some strides in correcting earlier missteps, like the Food and Drug Administration telling researchers in 1977 to exclude women of reproductive potential from early clinical trials. But stakeholders think agencies like the FDA could do more to incentivize the enrollment of women.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： How one patient went off dialysis — and others can too

leisure time

WSS

National associations that represent hospice owe an apology

Covid vaccines: Private market messier than government rollout

Wegovy improves function in certain heart failure patients

Researchers use wearables data and AI to predict preterm birth risk

Covid vaccines: Private market messier than government rollout

FDA advisory panel to debate high blood pressure devices

explore

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Jerome Adams on the need for new antivirals for Covid

Menendez indictment could see pharma lose a key ally

After affirmative action ruling, medical educators look to 'holistic review'

FDA advisory panel to debate high blood pressure devices

DIEP, the 'gold standard' of breast reconstruction, is under threat

Menendez indictment could see pharma lose a key ally

The high cost of giving birth even with insurance

As obesity drug market grows, telehealth companies court payers

Anesthesiologist group: stop taking Ozempic before surgery

FDA greenlights medical device to combat bladder issues

knowledge

Can U.S. cancer drug shortages be fixed?

FDA advisers vote against ALS treatment from BrainStorm

How the first Native Hawaiian psychiatrist helped diversify medicine

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Vivek Ramaswamy made waves in the debate, much as in biotech

Senator probes 340B programs at Cleveland Clinic, Bon Secours

leisure time

Wikipedia

hotspot

hotspot